Latest filing published 21 Dec 2015 for EPIRUS Biopharmaceuticals, Inc., €6,939.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Aurentz Vincent: trading record in brief
This profile gathers the share dealings of Aurentz Vincent in EPIRUS Biopharmaceuticals, Inc. The record holds 2 filings, for trades running from 9 December 2015 to 17 December 2015.
No open-market sale appears; the market trades are 2 purchases worth €17k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 21 December 2015, the filings show an open-market purchase worth €6,939 in EPIRUS Biopharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Aurentz Vincent
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,200 shares@ US$3.43Common StockSEC:0001104659-15-085920:0Canonical exit: 16 Mar 2016 (T+90)
- 2,800 shares@ US$3.85Common StockSEC:0001104659-15-084204:0Canonical exit: 8 Mar 2016 (T+90)
2 of 2 declarations
